| REGULATORY UPDATE |
|
| Year : 2018 | Volume
: 9
| Issue : 1 | Page : 48-50 |
|
|
Indian regulatory update: January-December 2017
Amita Bhave
Department of Regulatory Affairs, Global Drug Development India, Novartis India Limited, Mumbai, Maharashtra, India
Correspondence Address:
Ms. Amita Bhave
Novartis India Limited, Sandoz House, 5th Floor, Shivsagar Estate, Dr. Annie Besant Road, Worli, Mumbai - 400 018, Maharashtra
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/picr.PICR_176_17
|
|
|
This document provides updates in regulatory requirements regarding conduct of clinical trials in India.
|
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
